HYPERA S.A.
A Publicly-Held Corporation
Corporate Taxpayer ID (CNPJ) No. 02,932,074/0001-91
Company Registry (NIRE) 35,300,353,251
CVM Code No. 21431
NOTICE TO THE MARKET
HYPERA S.A. ("Company" or "Hypera Pharma") hereby informs that, pursuant to the provisions of article 12 of CVM Resolution No., 358, as of August 23rd, 2021, has received, on this date, a notice from Capital International Investors, an independent division of the Capital Research and Management Company ("Capital"), regarding the reduction of equity interest in the Company. Capital informed that manages 60,595,240 common shares of the Company, corresponding to approximately 9.5663% of its capital stock.
The equity movement does not change the corporate position of the Company' significant shareholders and/or its management structure.
Enclosed herewith is the letter sent by Capital.
São Paulo, May 8th, 2024
HYPERA S.A.
Adalmario Ghovatto Satheler do Couto
Investor Relations Officer
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Hypera SA published this content on 08 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 May 2024 03:32:02 UTC.